跳至主要内容
临床试验/NCT06141447
NCT06141447招募中2 期

Changes in Rate of Hemorrhage With Prophylactic Oxytocin for Second Trimester Dilation and Evacuation in the Clinic Setting

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年5月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
150
试验地点
1
主要终点
Hemorrhage

研究概览

简要总结

The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D&E) in the clinic setting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

This will be a double blinded study.

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • clinic-based D&E at 18 weeks gestational age and above
  • speaks English or Spanish

排除标准

  • refuses IV
  • history of coagulopathy
  • anticoagulant use in the preceding five days
  • chorioamnionitis or sepsis
  • suspected placenta accreta spectrum
  • intrauterine fetal demise
  • multiple gestation
  • use of misoprostol for cervical preparation

研究组 & 干预措施

Oxytocin

Experimental

Participants receive 40 units IV oxytocin in 1000 mL of normal saline at the time of tenaculum placement for D&E.

干预措施: Oxytocin + normal saline (Drug)

Placebo

Placebo Comparator

Participants receive 1000 mL of normal saline alone at the time of tenaculum placement for D&E.

干预措施: Normal saline (Drug)

结局指标

主要结局

Hemorrhage

时间窗: day of procedure

Quantitative blood loss greater than or equal to 500 mL or a clinical response to excessive bleeding such as transfusion or hospital admission

Quantitative blood loss

时间窗: day of procedure

Measured blood loss during procedure

次要结局

  • Procedure time(day of procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验